Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global Beta Glucan Based Products Market – Global Industry Insights

Beta glucan is a valuable dietary ?ber present in cereal crops, especially in barley, oat, and some mushrooms. According to the EC Nutrition journal: August 2017, beta glucans polysaccharide naturally found in the bran of cereal grains such as barley and oats and to a much lesser degree in rye and wheat, in amounts of around 7%, 5%, 2%, and less than 1%, respectively, the cell wall of baker’s yeast, certain types of fungi, and various types of mushrooms.

Beta glucans promote health in a number of ways. Beta-glucans have been studied for their hypocholesterolemic effects. Furthermore, beta-1, 3-glucans improve the body’s immune system defense against foreign invaders by enhancing the ability of macrophages, neutrophils, and natural killer cells to respond to and fight bacteria, viruses, fungi, and parasites.

Moreover, growth of beta glucan based products market is attributed to increasing usage of beta-glucan as an immunity booster medicine in pharmaceutical and nutraceutical industry due to increasing demand for beta glucan in food & beverages and pharmaceuticals industry and increasing consciousness and concern about health & wellness among the global population. 

The global beta glucan based products market size was valued at US$ 455.4 Mn in 2017 and is expected to witness a CAGR of 7.2% during the forecast period (2018 – 2026).


Global Beta Glucan Based Products Market Share (%), By Source, 2018 & 2026

Beta Glucan Based Products  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Changing consumer preferences towards the use of nutritious food supplements over synthetic ingredients is expected to drive the market growth during the forecast period Beta glucan is gaining interest among the population due to its multiple functional and bioactive properties. Beta glucan shows beneficial role in reducing insulin resistance, dyslipidemia, hypertension, and obesity. A study published in the Today’s Dietitian Journal: May 2014 stated that overweight men who consumed 7 g/day of beta-glucan for 12 weeks experienced a significant reduction in body mass, waist circumference, and visceral fat compared to those in the placebo group. 

Subsequently, the application of β-glucan as a food ingredient is being widely considered with dual purposes of increasing the fiber content of food products and enhancing their health properties. As prevalence of cardiovascular disease (CVD) is increasing, identifying functional foods that reduce CVD risk factors (including high blood cholesterol) is an important area of research. Thus, oat β-glucan, a soluble dietary fiber found in the endosperm cell walls of oats,  has gained considerable interest due to its cholesterol-lowering properties.

In December 2010, the Dietetic Products, Nutrition and Allergies panel of the European Food Safety Authority (EFSA) approved a health claim linking consumption of 3g of oat beta glucans per day with improved cholesterol levels.


Global Beta Glucan Based Products Market Share (%), By Grade, 2018 & 2026

Beta Glucan Based Products  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing application of beta glucans in various infectious disease treatments is further expected to aid in the market growth  

Various clinical and research studies support the application of beta glucan as a biological response modifier for the treatment of cancer and infectious diseases. However, the size and biochemical composition of β-glucans isolated from different sources affect their immunomodulatory properties.

Beta glucans are used in medical field to treat various diseases such as hyper cholesterolemia, diabetes, cancer, and HIV/AIDS. Beta glucans act as modulator for immune system. Moreover, it is used in the treatment of various cancers such as pulmonary malignancy, prostate cancer, and breast cancer. Beta glucans are also used for treatment of various types of diseases that are correlated with immune system infections.

  • Beta glucan act as anti-cancer agent, owing to the reduction of reactive oxygen species, which protects DNA from damage, whereas secondary reason is that it inhibits growth and further transformation of cancer cells
  • Oat beta glucan is a viscous, soluble fiber that can help maintain normal blood cholesterol and blood glucose levels as well as support gastrointestinal health
  • Beta glucans are also used to prevent infections after surgery, using PGG-glucans, a specific blend of beta-glucans. It intravenously (by IV) reduces the risk of infection after surgery. Beta-glucans also reduces the risk of a serious infection called sepsis in trauma patients.

According to the Frontiers in Immunology Journal: April 2018, β-glucans has potent hematopoietic activity, which enhances the production of hematopoietic factors, bone marrow recovery as well as stem cell homing and engraftment.   

Among region, Europe is expected to be the most lucrative region in the beta glucan based products market. In Europe, beta glucan products are readily offered by several key players, thereby creating competition for delivering efficient beta glucan based products and thus, lowering overall cost, ensuring easy end user access.

Regulatory authorities are imposing regulations and streamlining approval process for product approvals and easier access. Increasing engagement of regulatory bodies in approving health claims is favoring adoption of beta glucan products in this market and this is expected to drive growth of the market in the region. For instance, in November 2017, Council of the European Union authorized an extension of use of yeast beta-glucans as a novel food ingredient under Regulation (EC) No 258/97.

In November 2011, Commission Implementing Decision (EU) authorized, in accordance with Regulation (EC) No 258/97, stating that yeast beta-glucans as a novel food ingredient to be used in certain foods and foodstuffs, including beverages as well as in food supplements and in food for special medical purposes and total diet replacement for weight control.   

Key players operating in the beta glucan based products market include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc. and AIPPO.

Beta glucan is an important component of dietary fiber, which can be extracted from oat, barley, bacteria, and yeast. It possesses several physiological effects, including lowering plasma cholesterol level, control of postprandial glucose level, and immune modulation effects. Apart from the food industry, beta glucan is increasingly being used in the pharmaceutical, medical, cosmetic, and industrial applications, and end product manufacturing. 

Βeta glucans can act as an immune system modulator and also has the ability to reduce blood glucose, and it may be used in the treatment of diabetes mellitus. Beta glucans can protect the body from heart attack by lowering cholesterol levels and it also acts as an anti-tumor agent. Beta glucans are used in medical field to treat various diseases including hyper cholesterolemia, diabetes, cancer, and HIV/AIDS.

Market Dynamics

Increasing applications of beta glucan as potential active ingredient in various food, medical, pharmaceutical, animal feed, and industrial applications is expected to increase demand for beta glucan and this is expected to aid in growth of the market in the near future. Moreover, health benefits of beta glucan along with changing consumer preferences towards use of nutritious food and dietary supplements among global population is expected to propel the market growth.

Furthermore, key players in the market are focusing on gaining significant market share by adopting various strategies and this is expected to aid in the market growth. For instance, in April 2017, Kemin Industries acquired a beta-glucan manufacturing technology from Algal Scientific, a company headquartered in Plymouth, U.S. In October 2014, NutraQ announced that it entered into a distribution partnership with American International Chemical LLC (AIC) to exclusively distribute NBG range of beta-glucans in in the U.S., Canada, and Mexico.

Key features of the study:

  • This report provides in-depth analysis of beta glucan based products market and provides market size (US$ Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market
  • This study also provides key insights into market drivers, restraints, opportunities, scoliosis management product approval & launch, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global beta glucan based products market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as part of this study include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc., and AIPPO
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, manufacturing up-gradation, market expansion, and marketing tactics
  • The global beta glucan based products market report caters to various stakeholders in this industry including investors, suppliers, beta glucan based product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the beta glucan based products market

Detailed Segmentation:

  • Global Beta Glucan Based Products Market, By Source:
    • Cereals
    • Yeast
    • Mushroom
    • Others
  • Global Beta Glucan Based Products Market, By Grade:
    • Pharma
    • Medical
    • Food
    • Cosmetics
    • Enhanced Oil Recovery (EOR)
    • Animal Feed     
  • Global Beta Glucan Based Products Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Source:
        • Cereals
        • Yeast
        • Mushroom
        • Others
      • By Grade
        • Pharma
        • Medical
        • Food
        • Cosmetics
        • Enhanced Oil Recovery (EOR)
        • Animal Feed
    • Europe
      • By Country:
        • Germany
        • France
        • Italy
        • U.K.
        • Spain
        • Russia
        • Rest of Europe
      • By Source:
        • Cereals
        • Yeast
        • Mushroom
        • Others
      • By Grade
        • Pharma
        • Medical
        • Food
        • Cosmetics
        • Enhanced Oil Recovery (EOR)
        • Animal Feed
    • Asia Pacific
      • By Country:
        • China
        • India
        • Japan
        • South Korea
        • Australia
        • Rest of Asia Pacific
      • By Source:
        • Cereals
        • Yeast
        • Mushroom
        • Others
      • By Grade
        • Pharma
        • Medical
        • Food
        • Cosmetics
        • Enhanced Oil Recovery (EOR)
        • Animal Feed
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Source:
        • Cereals
        • Yeast
        • Mushroom
        • Others
      • By Grade
        • Pharma
        • Medical
        • Food
        • Cosmetics
        • Enhanced Oil Recovery (EOR)
        • Animal Feed
    • Latin America
      • By Country:
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
      • By Source:
        • Cereals
        • Yeast
        • Mushroom
        • Others
      • By Grade
        • Pharma
        • Medical
        • Food
        • Cosmetics
        • Enhanced Oil Recovery (EOR)
        • Animal Feed
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Source:
        • Cereals
        • Yeast
        • Mushroom
        • Others
      • By Grade
        • Pharma
        • Medical
        • Food
        • Cosmetics
        • Enhanced Oil Recovery (EOR)
        • Animal Feed
  • Company Profiles
    • Merck KGaA*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments
      • Strategies
    • Jkosmmune
    • Lesaffre Group
    • Garuda International, Inc.
    • Ohly GmBH
    • Koninklijke DSM N.V.
    • Kerry Group PLC
    • STR Biotech Co. Ltd.
    • Macrocare Tech Co., Ltd.
    • Amarte USA, LLC
    • Ceapro Inc.
    • Biotec Pharmacon ASA
    • Quegen Biotech Co., Ltd.
    • Kemin Industries, Inc.
    • NutraQ AS
    • Lantmännen
    • Carbon Medical Technologies, Inc.
    • Givaudan SA
    • Danaher Corporation
    • Super Beta Glucan Inc.
    • AIPPO

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Source
      • Market Snippet, By Grade
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Impact Analysis
    • FDA Approval Information
    • Mergers and Acquisitions/Collaborations
    • Product Launch and Approval
    • Beta Glucan Content in Different Sources
    • Beta Glucan Yields And Production Technologies From Various Sources
    • Industrial Applications of Beta Glucans
    • Clinical Studies and Research & Development Activities
    • Supply Chain Analysis
    • Porter’s Analysis
  4. Global Beta Glucan Based Products Market, By Source, 2018 - 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 - 2026
      • Segment Trends
    • Cereals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Yeast
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Mushroom
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  5. Global Beta Glucan Based Products Market, By Grade, 2018 - 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 - 2026
      • Segment Trends
    • Pharma
      • Introduction
      • Market Size, Product Volume and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million, Units)
    • Medical
      • Introduction
      • Market Size, Product Volume and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million, Units)
    • Food
      • Introduction
      • Market Size, Product Volume and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million, Units)
    • Cosmetics
      • Introduction
      • Market Size, Product Volume and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million, Units)
    • Enhanced Oil Recovery
      • Introduction
      • Market Size, Product Volume and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million, Units)
    • Animal Feed
      • Introduction
      • Market Size, Product Volume and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million, Units)
  6. Global Beta Glucan Based Products Market, By Region, 2018 - 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • North America
      • Market Size and Forecast, By Source, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Grade, 2018 - 2026, (US$ Million, Units)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Source, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Grade, 2018 - 2026, (US$ Million, Units)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Source, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Grade, 2018 - 2026, (US$ Million, Units)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Source, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Grade, 2018 - 2026, (US$ Million, Units)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Source, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Grade, 2018 - 2026, (US$ Million, Units)
      • Market Size and Forecast, By Country/Region, 2018 - 2026, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Source, 2018 - 2026, (US$ Million)
      • Market Size and Forecast, By Grade, 2018 - 2026, (US$ Million, Units)
      • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Company Profiles
      • Merck KGaA
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Jkosmmune
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Lesaffre Group
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Garuda International, Inc.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Ohly GmBH
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Koninklijke DSM N.V.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Kerry Group PLC
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • STR Biotech Co. Ltd.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Macrocare Tech Co., Ltd.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Amarte USA, LLC
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Ceapro Inc.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Biotec Pharmacon ASA
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Quegen Biotech Co., Ltd.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Kemin Industries, Inc.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • NutraQ AS
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Lantmännen
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Carbon Medical Technologies, Inc.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Givaudan SA
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Danaher Corporation
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • Super Beta Glucan Inc.
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
      • AIPPO
        • Company Overview
        • Source Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Key Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 30 figures on "Beta Glucan Based Products Market - Global forecast to 2026”.

 

Frequently Asked Questions

The global beta glucan based products market is estimated to surpass US$ 849.2 Million by 2026.
Major players operating in the global beta glucan based products market include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc., and AIPPO.
Changing consumer preferences towards usage of nutritious food supplements over synthetic ingredients is one of the major factors that is expected to propel growth of the market over the forecast period.
The global beta glucan based products market is estimated to exhibit a CAGR of 7.2% over the forecast period.
Among regions, Europe is expected to be the most lucrative region in the beta glucan based products market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner